Publication | Closed Access
The role of MAPK pathway in bone and soft tissue tumors.
39
Citations
20
References
2011
Year
U0126 blocks MAPK signaling and decreases cell proliferation in OS and MFH. Thus, selective MAPK inhibitors might be therapeutically advantageous in the treatment of bone and soft tissue sarcomas.
| Year | Citations | |
|---|---|---|
Page 1
Page 1